Summary
Target Corporation (TGT) filed an 8-K on December 16, 2015, reporting the closing of its previously announced sale of its pharmacy and clinic businesses to CVS Pharmacy, Inc. (CVS). This filing formalizes the completion of the transaction that was initially agreed upon in June 2015. The core of this report is the execution of the Pharmacy Operating Agreement (POC) with CVS, which is directly linked to the Asset Purchase Agreement (APA) for the sale of these healthcare assets. For investors, this 8-K signifies the definitive conclusion of Target's divestiture of its pharmacy and clinic operations. This strategic move allows Target to focus its resources on its core retail business. While the financial implications of the sale were detailed in the initial June filing, this report confirms the operational closure, marking a significant shift in Target's business model and operational footprint. Investors should note that Target will no longer be operating these healthcare-related services.
Key Highlights
- 1Target Corporation finalized the sale of its pharmacy and clinic businesses to CVS Pharmacy, Inc. on December 16, 2015.
- 2The filing of the Pharmacy Operating Agreement (POC) with CVS marks the closing of the transaction.
- 3This agreement is in connection with the Asset Purchase Agreement (APA) originally announced on June 12, 2015.
- 4The transaction involves the sale of Target's pharmacy and clinic operations to CVS.
- 5This 8-K serves to officially report the completion of the divestiture, confirming the operational exit from these healthcare segments.
- 6Investors can refer to the Form 8-K filed on June 15, 2015, for the material terms of the APA and POC.